![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ALG6 |
Gene summary for ALG6 |
![]() |
Gene information | Species | Human | Gene symbol | ALG6 | Gene ID | 29929 |
Gene name | ALG6 alpha-1,3-glucosyltransferase | |
Gene Alias | CDG1C | |
Cytomap | 1p31.3 | |
Gene Type | protein-coding | GO ID | GO:0006464 | UniProtAcc | Q9Y672 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
29929 | ALG6 | LZE4T | Human | Esophagus | ESCC | 3.77e-05 | 9.18e-02 | 0.0811 |
29929 | ALG6 | LZE8T | Human | Esophagus | ESCC | 1.37e-04 | 1.28e-01 | 0.067 |
29929 | ALG6 | LZE24T | Human | Esophagus | ESCC | 1.56e-11 | 2.20e-01 | 0.0596 |
29929 | ALG6 | LZE21T | Human | Esophagus | ESCC | 8.06e-03 | 1.43e-01 | 0.0655 |
29929 | ALG6 | LZE6T | Human | Esophagus | ESCC | 1.82e-04 | 1.32e-01 | 0.0845 |
29929 | ALG6 | P2T-E | Human | Esophagus | ESCC | 1.51e-30 | 4.56e-01 | 0.1177 |
29929 | ALG6 | P4T-E | Human | Esophagus | ESCC | 8.85e-18 | 3.64e-01 | 0.1323 |
29929 | ALG6 | P5T-E | Human | Esophagus | ESCC | 1.42e-08 | 1.20e-01 | 0.1327 |
29929 | ALG6 | P8T-E | Human | Esophagus | ESCC | 9.53e-11 | 1.74e-01 | 0.0889 |
29929 | ALG6 | P9T-E | Human | Esophagus | ESCC | 6.77e-05 | 1.10e-01 | 0.1131 |
29929 | ALG6 | P10T-E | Human | Esophagus | ESCC | 1.31e-17 | 2.81e-01 | 0.116 |
29929 | ALG6 | P11T-E | Human | Esophagus | ESCC | 1.73e-06 | 2.41e-01 | 0.1426 |
29929 | ALG6 | P12T-E | Human | Esophagus | ESCC | 1.55e-11 | 2.16e-01 | 0.1122 |
29929 | ALG6 | P15T-E | Human | Esophagus | ESCC | 3.52e-13 | 1.91e-01 | 0.1149 |
29929 | ALG6 | P16T-E | Human | Esophagus | ESCC | 5.58e-12 | 2.21e-01 | 0.1153 |
29929 | ALG6 | P17T-E | Human | Esophagus | ESCC | 3.80e-02 | 8.45e-02 | 0.1278 |
29929 | ALG6 | P20T-E | Human | Esophagus | ESCC | 1.63e-10 | 2.05e-01 | 0.1124 |
29929 | ALG6 | P21T-E | Human | Esophagus | ESCC | 3.68e-24 | 3.12e-01 | 0.1617 |
29929 | ALG6 | P22T-E | Human | Esophagus | ESCC | 5.05e-11 | 1.26e-01 | 0.1236 |
29929 | ALG6 | P23T-E | Human | Esophagus | ESCC | 3.05e-18 | 4.40e-01 | 0.108 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000648611 | Oral cavity | LP | protein glycosylation | 73/4623 | 226/18723 | 5.72e-03 | 3.44e-02 | 73 |
GO:004341311 | Oral cavity | LP | macromolecule glycosylation | 73/4623 | 226/18723 | 5.72e-03 | 3.44e-02 | 73 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0051023 | Esophagus | ESCC | N-Glycan biosynthesis | 39/4205 | 53/8465 | 3.26e-04 | 1.15e-03 | 5.89e-04 | 39 |
hsa0051033 | Esophagus | ESCC | N-Glycan biosynthesis | 39/4205 | 53/8465 | 3.26e-04 | 1.15e-03 | 5.89e-04 | 39 |
hsa005105 | Oral cavity | OSCC | N-Glycan biosynthesis | 39/3704 | 53/8465 | 9.77e-06 | 4.36e-05 | 2.22e-05 | 39 |
hsa0051012 | Oral cavity | OSCC | N-Glycan biosynthesis | 39/3704 | 53/8465 | 9.77e-06 | 4.36e-05 | 2.22e-05 | 39 |
hsa0051022 | Oral cavity | LP | N-Glycan biosynthesis | 31/2418 | 53/8465 | 4.86e-06 | 4.14e-05 | 2.67e-05 | 31 |
hsa0051032 | Oral cavity | LP | N-Glycan biosynthesis | 31/2418 | 53/8465 | 4.86e-06 | 4.14e-05 | 2.67e-05 | 31 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ALG6 | SNV | Missense_Mutation | novel | c.823G>T | p.Val275Leu | p.V275L | Q9Y672 | protein_coding | deleterious(0.03) | benign(0.307) | TCGA-A2-A1FW-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | cytoxan | SD |
ALG6 | SNV | Missense_Mutation | novel | c.823N>T | p.Val275Leu | p.V275L | Q9Y672 | protein_coding | deleterious(0.03) | benign(0.307) | TCGA-A2-A1G0-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | SD |
ALG6 | SNV | Missense_Mutation | novel | c.823N>T | p.Val275Leu | p.V275L | Q9Y672 | protein_coding | deleterious(0.03) | benign(0.307) | TCGA-A8-A09V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD |
ALG6 | SNV | Missense_Mutation | c.112N>G | p.Tyr38Asp | p.Y38D | Q9Y672 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-BH-A0W7-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | CR | |
ALG6 | insertion | Nonsense_Mutation | novel | c.656_657insATCTCTTCACTAAGCTTTTATTTGAAAGGTAAAGTACAGA | p.Phe219LeufsTer5 | p.F219Lfs*5 | Q9Y672 | protein_coding | TCGA-AO-A03R-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD | ||
ALG6 | SNV | Missense_Mutation | c.1507C>G | p.Gln503Glu | p.Q503E | Q9Y672 | protein_coding | tolerated(0.05) | benign(0.003) | TCGA-C5-A1M7-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
ALG6 | SNV | Missense_Mutation | c.1277N>A | p.Arg426Lys | p.R426K | Q9Y672 | protein_coding | tolerated(0.9) | benign(0.007) | TCGA-JW-A5VL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
ALG6 | insertion | Frame_Shift_Ins | novel | c.1088_1089insT | p.Met365TyrfsTer12 | p.M365Yfs*12 | Q9Y672 | protein_coding | TCGA-BI-A0VR-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unknown | Unknown | SD | ||
ALG6 | deletion | Frame_Shift_Del | novel | c.1228_1229delAA | p.Lys410AspfsTer3 | p.K410Dfs*3 | Q9Y672 | protein_coding | TCGA-EA-A3HU-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | ||
ALG6 | insertion | Nonsense_Mutation | novel | c.894_895insATAATGAGGTAAGAGAAACAAAGTTTGTATGTAGTATTTT | p.Ser301ArgfsTer2 | p.S301Rfs*2 | Q9Y672 | protein_coding | TCGA-MA-AA43-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |